Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Tang, Juanjuan
Zhu, Xunmin
Zhao, Jingjing
Fung, Mingchiu
Li, Yinyan
Gao, Zhiyan
Yan, Suikai
Li, Xiaomin
Ji, Xiaofang
Su, Fang
Li, Zi
and
Zhao, Dezheng
2015.
Tissue Transglutaminase‐Regulated Transformed Growth Factor‐β1 in the Parasite Links Schistosoma japonicum Infection with Liver Fibrosis.
Mediators of Inflammation,
Vol. 2015,
Issue. 1,
Zhen, Yong-Zhan
Li, Na-Ren
He, Hong-Wei
Zhao, Shuang-Shuang
Zhang, Guang-Ling
Hao, Xiao-Fang
and
Shao, Rong-Guang
2015.
Protective effect of bicyclol against bile duct ligation-induced hepatic fibrosis in rats.
World Journal of Gastroenterology,
Vol. 21,
Issue. 23,
p.
7155.
Abd El-Aal, Naglaa Fathy
Hamza, Rania Said
and
Harb, Ola
2017.
Paeoniflorin targets apoptosis and ameliorates fibrosis in murine schistosomiasis mansoni : A novel insight.
Experimental Parasitology,
Vol. 183,
Issue. ,
p.
23.
Wan, Chunpeng
Jin, Fen
Du, Youqin
Yang, Kang
Yao, Liangliang
Mei, Zhigang
and
Huang, Weifeng
2017.
Genistein improves schistosomiasis liver granuloma and fibrosis via dampening NF-kB signaling in mice.
Parasitology Research,
Vol. 116,
Issue. 4,
p.
1165.
Carson, Jack P.
Ramm, Grant A.
Robinson, Mark W.
McManus, Donald P.
and
Gobert, Geoffrey N.
2018.
Schistosome-Induced Fibrotic Disease: The Role of Hepatic Stellate Cells.
Trends in Parasitology,
Vol. 34,
Issue. 6,
p.
524.
Sobhy, Maysa Mohamed Kamel
Mahmoud, Soheir Sayed
El-Sayed, Shaimaa Helmy
Rizk, Enas Mohamed Ali
Raafat, Amira
and
Negm, Mohamed Sherif Ismail
2018.
Impact of treatment with a Protein Tyrosine Kinase Inhibitor (Genistein) on acute and chronic experimental Schistosoma mansoni infection.
Experimental Parasitology,
Vol. 185,
Issue. ,
p.
115.
Jia, Zongxiang
Gong, Yan
Pi, Yufang
Liu, Xueying
Gao, Lipeng
Kang, Liqing
Wang, Jing
Yang, Fan
Tang, Jie
Lu, Weiyue
Li, Qinghua
Zhang, Wei
Yan, Zhiqiang
and
Yu, Lei
2018.
pPB Peptide-Mediated siRNA-Loaded Stable Nucleic Acid Lipid Nanoparticles on Targeting Therapy of Hepatic Fibrosis.
Molecular Pharmaceutics,
Vol. 15,
Issue. 1,
p.
53.
Kamdem, Severin Donald
Moyou-Somo, Roger
Brombacher, Frank
and
Nono, Justin Komguep
2018.
Host Regulators of Liver Fibrosis During Human Schistosomiasis.
Frontiers in Immunology,
Vol. 9,
Issue. ,
Almeer, Rafa S.
El-Khadragy, Manal F.
Abdelhabib, Semlali
Abdel Moneim, Ahmed E.
and
Sheweita, Salah A.
2018.
Ziziphus spina-christi leaf extract ameliorates schistosomiasis liver granuloma, fibrosis, and oxidative stress through downregulation of fibrinogenic signaling in mice.
PLOS ONE,
Vol. 13,
Issue. 10,
p.
e0204923.
Mirzavand, Somayeh
Rafiei, Abdollah
Teimoori, Ali
Khorsandi, Layasadat
Bahreini, Amin
Motamedfar, Azim
and
Beiromvand, Molouk
2020.
Gene expression in human liver fibrosis associated with Echinococcus granulosus sensu lato.
Parasitology Research,
Vol. 119,
Issue. 7,
p.
2177.
Da, Jingjing
Yang, Yuqi
Dong, Rong
Shen, Yan
and
Zha, Yan
2020.
Therapeutic effect of 1,25(OH)2-VitaminD3 on fibrosis and angiogenesis of peritoneum induced by chlorhexidine.
Biomedicine & Pharmacotherapy,
Vol. 129,
Issue. ,
p.
110431.
Kong, Hongyan
He, Jinan
Guo, Shusen
Song, Qiqin
Xiang, Dandan
Tao, Ran
Yu, Haijing
Chen, Guang
Huang, Zhiyong
Ning, Qin
Huang, Jiaquan
and
MacDonald, Andrew Scott
2020.
Endothelin receptors promote schistosomiasis-induced hepatic fibrosis via splenic B cells.
PLOS Pathogens,
Vol. 16,
Issue. 10,
p.
e1008947.
Santana, Jordana Batista
de Almeida, Tarcísio Vila Verde Santana
Lopes, Diego Mota
Page, Brady
Oliveira, Sergio Costa
Souza, Irismá
Ribeiro, Luís Eduardo Viana Silva
Gutiérrez, Néstor Adrián Guerrero
Carvalho, Edgar M.
and
Cardoso, Luciana Santos
2021.
Phenotypic Characterization of CD4+ T Lymphocytes in Periportal Fibrosis Secondary to Schistosomiasis.
Frontiers in Immunology,
Vol. 12,
Issue. ,
Zheng, Li
Wang, Lixia
Hu, Yuan
Yi, Jia
Wan, Lun
Shen, Yujuan
Liu, Si
Zhou, Xiaorong
and
Cao, Jianping
2021.
Higher frequency of circulating Vδ1 γδT cells in patients with advanced schistosomiasis.
Parasite Immunology,
Vol. 43,
Issue. 10-11,
Zhang, Xiaoling
Zhang, Xiaoyan
Huang, Wenmin
and
Ge, Xiaoqun
2021.
The role of heat shock proteins in the regulation of fibrotic diseases.
Biomedicine & Pharmacotherapy,
Vol. 135,
Issue. ,
p.
111067.
Zhou, Liyue
Li, Yifan
Liang, Qiangwei
Liu, Jinxia
and
Liu, Yanhua
2022.
Combination therapy based on targeted nano drug co-delivery systems for liver fibrosis treatment: a review.
Journal of Drug Targeting,
Vol. 30,
Issue. 6,
p.
577.
Abd El-Fattah, Eslam E.
and
Zakaria, Amr Y.
2022.
Targeting HSP47 and HSP70: promising therapeutic approaches in liver fibrosis management.
Journal of Translational Medicine,
Vol. 20,
Issue. 1,
Lønsmann, Ida
Gudmann, Natasja Stæhr
Manon-Jensen, Tina
Thiele, Maja
Moreno, Ydalina Maria
Langholm, Lasse Løcke
Nielsen, Mette Juul
Detlefsen, Sönke
Karsdal, Morten Asser
Krag, Aleksander Ahm
and
Leeming, Diana Julie
2022.
Serologically assessed heat shock protein 47 is related to fibrosis stage in early compensated alcohol-related liver disease.
Clinical Biochemistry,
Vol. 104,
Issue. ,
p.
36.
Guo, Ting
Wantono, Cindy
Tan, Yuyong
Deng, Feihong
Duan, Tianying
and
Liu, Deliang
2023.
Regulators, functions, and mechanotransduction pathways of matrix stiffness in hepatic disease.
Frontiers in Physiology,
Vol. 14,
Issue. ,
Luangmonkong, Theerut
Parichatikanond, Warisara
and
Olinga, Peter
2023.
Targeting collagen homeostasis for the treatment of liver fibrosis: Opportunities and challenges.
Biochemical Pharmacology,
Vol. 215,
Issue. ,
p.
115740.